Therapeutic Defibrination and Heparin Therapy in the Prevention and Resolution of Experimental Venous Thrombosis
- 1 October 1970
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 42 (4), 729-737
- https://doi.org/10.1161/01.cir.42.4.729
Abstract
The application of phenol to the femoral veins of anesthetized dogs resulted in an occluding thrombus in 24 of 25 veins at 1 week. Serial venography and eventual histology showed that these veins remained occluded over a 5-week observation period, the thrombi undergoing organization. Therapeutic defibrination was achieved with administration of an enzyme from venom of the pit viper (Arvin). Arvin, administered for 1 week immediately following phenol application and before thrombus formation had occurred, prevented thrombosis in all 10 such veins, and serial venography for a further 4 weeks showed that the veins remained patent. Administration of Arvin was begun 24 hours postoperatively, when venography had demonstrated an occluding thrombus and failed to clear any of 11 veins after 3 weeks of treatment. Intravenous administration of heparin, 10,000 units, at 6, 6, and 12-hour intervals in a 24-hour period, was begun immediately after phenol application and continued for 1 week; 10 of 12 veins were blocked at 1 week. Following the same dose of heparin every 6 hours four of eight veins were blocked at 1 week. The results indicate that when the vascular endothelium is damaged, therapeutic defibrination is more effective than heparin therapy in preventing venous thrombosis. Arvin therapy has no significant thrombolytic effect even if the thrombus is less than 24 hours old.Keywords
This publication has 11 references indexed in Scilit:
- Treatment of Deep Vein Thrombosis. A Trial of Heparin, Streptokinase, and ArvinBMJ, 1969
- The Effect of Arvin on Blood Coagulation FactorsBritish Journal of Haematology, 1968
- An experimental model for the study of thrombosisBritish Journal of Surgery, 1968
- THERAPEUTIC DEFIBRINATION IN THE TREATMENT OF THROMBOTIC DISEASEThe Lancet, 1968
- In vivo effects of Agkistrodon rhodostoma venom: studies with fibrinogen-131I.JCI Insight, 1966
- FIBRINOLYSIS AND THE DEFIBRINATION SYNDROME OF MALAYAN VIPER BITEThe Lancet, 1964
- PROLONGED COAGULATION DEFECT (DEFIBRINATION SYNDROME) IN MALAYAN VIPER BITEThe Lancet, 1963
- Studies on the character and staining of fibrinJournal of Clinical Pathology, 1962
- Comparative Effects of Dicoumarol, Tromexan, and Heparin on Thrombus Propagation*Annals of Surgery, 1960
- Studies in the Production of “Standard” Venous Thrombosis*Annals of Surgery, 1959